4-Chloroacetyl-piperazine-1-carboxylic acid tert-butyl ester, 98.0%, 250mg

2-(o-tolyl)-1,3,2-dioxaborinane, 98+%, 1g

3,3'-Diiodo-L-thyronine, 95.0%, 250mg

(R)-(-)-2-Phenylglycine chloride hydrochloride, 95.0%, 1g

2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid, 50mg

3-(Toluene-4-sulfonyloxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

2-Propenamide, 3-phenyl-N-[2,2,2-trichloro-1-[[[(4-chlorophenyl)amino]thioxomethyl]amino]ethyl]-, (2E)-, 25mg

3-Bromo-4-methyl-1H-pyrazole, 95.0%, 25g

7-Hydroxy-1,2,3,4-tetrahydroquinoline, 98.0%, 25g

2-Fluoro-5-iodotoluene, 99.0%, 10g

1,5-Dihydro-pyrrolo[3,2-d]pyrimidine-2,4-dione, 95.0%, 1g

Plateaux d'incubation Blot, MINI, 5 Pièce(s)

4-chloro-N,N-dimethyl-6-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 5g